ECC + FOLFIRI
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Stomach Cancer
Conditions
Stomach Cancer, Neoplasm Metastasis
Trial Timeline
Jun 1, 2005 → Dec 1, 2009
NCT ID
NCT00374036About ECC + FOLFIRI
ECC + FOLFIRI is a phase 3 stage product being developed by Roche for Stomach Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT00374036. Target conditions include Stomach Cancer, Neoplasm Metastasis.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00374036 | Phase 3 | Completed |
Competing Products
20 competing products in Stomach Cancer